Real-world data on tolerability of COVID-19 vaccination in patients with rheumatoid arthritis based on patient-reported outcomes.
Martin FeuchtenbergerMagdolna Szilvia KovacsAnna EderAxel NiggGiovanni AlmanzarMartina PrelogArne SchäferPublished in: Rheumatology advances in practice (2024)
Based on these real-world data, tolerability of COVID-19 vaccination was very good in both RA patients and controls. Reservations against COVID-19 vaccination were rare overall, but if present, associated with a significantly worse tolerability and a significantly lower degree of recommendation.
Keyphrases
- patient reported outcomes
- coronavirus disease
- sars cov
- open label
- end stage renal disease
- electronic health record
- ejection fraction
- newly diagnosed
- big data
- chronic kidney disease
- double blind
- rheumatoid arthritis
- placebo controlled
- respiratory syndrome coronavirus
- prognostic factors
- peritoneal dialysis
- clinical trial
- randomized controlled trial
- systemic lupus erythematosus
- ankylosing spondylitis
- disease activity
- data analysis
- idiopathic pulmonary fibrosis
- artificial intelligence
- patient reported